|
(Rac)-NMDAR antagonist 1
|
|
2435557-99-4
|
|
Narmafotinib
|
|
1393653-34-3
|
|
Naphthoquine phosphate
|
|
173531-58-3
|
|
NVP-BHG712 isomer
|
|
2245892-85-5
|
|
N-p-trans-Coumaroyltyramine
|
|
36417-86-4
|
|
N-(3-Methoxybenzyl)Palmitamide
|
|
847361-96-0
|
|
N3-PEG3-CH2CH2COOH
|
|
1056024-94-2
|
|
NMS-P715
|
|
1202055-32-0
|
|
NSC 601980
|
|
2070018-27-6
|
|
NF-56-EJ40
|
|
2380230-73-7
|
|
NCRW0005-F05
|
|
342779-66-2
|
|
Nelociguat
|
|
625115-52-8
|
|
Niga-ichigoside F1
|
|
95262-48-9
|
|
Norwogonin
|
|
4443-09-8
|
|
NRC-2694
|
|
936446-61-6
|
|
Nigranoic acid
|
|
39111-07-4
|
|
Nampt-IN-3
|
|
2121591-52-2
|
|
NS3861
|
|
216853-59-7
|
|
Namitecan
|
|
372105-27-6
|
|
Nav1.1 activator 1
|
|
2332897-85-3
|
|
NMS-P515
|
|
1262395-13-0
|
|
NCGC00244536
|
|
2003260-55-5
|
|
Niraparib metabolite M1
|
|
1476777-06-6
|
|
Neoseptin 3
|
|
1622863-21-1
|
|
N-Nornuciferine
|
|
4846-19-9
|
|
β-Neo-Endorphin
|
|
77739-21-0
|
|
Nodosin
|
|
10391-09-0
|
|
NU6300
|
|
2070015-09-5
|
|
NaV1.7 inhibitor-1
|
|
1494585-79-3
|
|
NSP-AS
|
|
211106-69-3
|
|
NFATc1-IN-1
|
|
1912422-56-0
|
|
Naquotinib mesylate
|
|
1448237-05-5
|
|
N-Feruloyloctopamine
|
|
66648-44-0
|
|
NFAT Transcription Factor Regulator-1
|
|
245747-71-1
|
|
NCGC00229600
|
|
1338824-20-6
|
|
Nav1.7-IN-2
|
|
1332295-35-8
|
|
NLRP3-IN-11
|
|
2769040-91-5
|
|
N1,N3,N5-Tris(4-dodecylhexadecyl)benzene-1,3,5-tricarboxamide
|
|
2922283-38-1
|
|
Nampt-IN-1
|
|
1698878-14-6
|
|
N-(3-Methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide
|
|
883715-23-9
|
|
Nagilactone B
|
|
19891-51-1
|
|
Nemorubicin
|
|
108852-90-0
|
|
NRX-2663
|
|
2763260-34-8
|
|
Navitoclax-piperazine
|
|
2143096-93-7
|
|
Notoginsenoside R2
|
|
80418-25-3
|
|
NVX-207
|
|
745020-66-0
|
|
NCT-506
|
|
2231098-99-8
|
|
[Leu31,Pro34]-Neuropeptide Y (porcine)
|
|
125580-28-1
|
|
NCI172112
|
|
56605-16-4
|
|
NHE3-IN-2
|
|
92434-13-4
|
|
4-Nonylphenol-d5
|
|
358730-95-7
|
|
NLRP3/AIM2-IN-2
|
|
791840-86-3
|
|
Nateglinide-d5
|
|
1227666-13-8
|
|
Nevadensin
|
|
10176-66-6
|
|
Necroptosis-IN-1
|
|
1391980-92-9
|
|
NAI-N3
|
|
1612756-29-2
|
|
Neocryptotanshinone
|
|
109664-02-0
|
|
N-Boc-Phe-Leu-Phe-Leu-Phe
|
|
148182-34-7
|
|
NucPE1
|
|
1404091-23-1
|
|
Niclosamide-13C6
|
|
1325808-64-7
|
|
NAMPT inhibitor-linker 1
|
|
2241019-57-6
|
|
N-acetyl Dapsone-d4
|
|
2070015-08-4
|
|
Nelonemdaz potassium
|
|
916214-57-8
|
|
N-deacetylated BMS-202
|
|
2310135-18-1
|
|
NS2B/NS3-IN-3
|
|
2832876-90-9
|
|
N7-Methyl-guanosine-5'-triphosphate-5'-adenosine diammonium
|
|
75252-10-7
|
|
Naproxen etemesil
|
|
385800-16-8
|
|
NK1 receptor antagonist 2
|
|
579475-17-5
|
|
Nigakinone
|
|
18110-86-6
|
|
NBDHEX
|
|
787634-60-0
|
|
NCT02
|
|
790245-61-3
|
|
NRP1 antagonist 1
|
|
2569598-01-0
|
|
Nitecapone
|
|
116313-94-1
|
|
Nicodicosapent
|
|
1269181-69-2
|
|
N-β-alanyldopamine hydrochloride
|
|
58077-93-3
|
|
NF-κB/MAPK-IN-1
|
|
2413940-56-2
|
|
NPD-1335
|
|
2376326-31-5
|
|
Nucleoprotein (396-404)
|
|
158475-79-7
|
|
NVS-SM2
|
|
1562333-92-9
|
|
Nuvenzepine
|
|
96487-37-5
|
|
Niraparib (R-enantiomer)
|
|
1038915-58-0
|
|
NPPM 6748-481
|
|
432020-20-7
|
|
NHS-SS-Ph
|
|
2750799-12-1
|
|
NRX-252262
|
|
2438637-61-5
|
|
Nrf2 activator-4
|
|
2383016-68-8
|
|
NSP-805
|
|
125068-54-4
|
|
NHWD-870
|
|
2115742-03-3
|
|
NSC 694621
|
|
104857-29-6
|
|
NLRP3-IN-13
|
|
1704638-35-6
|
|
NCGC00029283
|
|
714240-31-0
|
|
NH-3
|
|
447415-26-1
|
|
N-Desethyl amodiaquine dihydrochloride
|
|
79049-30-2
|
|
NMDI14
|
|
307519-88-6
|
|
N-[(4-Aminophenyl)methyl]adenosine
|
|
95523-13-0
|
|
NUCC-390 dihydrochloride
|
|
2749281-71-6
|
|
N-ε-propargyloxycarbonyl-L-lysine hydrochloride
|
|
1428330-91-9
|
|
N6-(4-Hydroxybenzyl)adenosine
|
|
110505-75-4
|
|
NSC639828
|
|
134742-26-0
|
|
NF-κΒ activator 1
|
|
2387524-59-4
|
|
NSC 694623
|
|
907957-34-0
|